Diagnosis of MCI due to AD is an opportunity for meaningful interventions
Doctors have access to a range of evidence-based early interventions after diagnosis of MCI due to AD.3 Early diagnosis also provides the opportunity to prepare financial and end-of-life plans while cognitive impairment remains mild.
The current pharmacological landscape for managing patients with Alzheimer’s disease includes symptomatic treatments, clinical trials, and treatments for comorbidities such as depression.
Nonpharmacological interventions may help change the direction of cognitive decline
In the 2-year observational FINGER study, elderly patients showed 25 to 150% improvements in cognition due to non-pharmaceutical post-testing interventions.
25% change in overall cognition (as measured through a comprehensive neuropsychological test battery)
83% improvement in executive function
150% improvement in processing speed
Care partner interventions are an important component of overall care
As of 2017, 48% of care partners were unpaid while caring for a spouse, parent, or family member. Dementia care partners tend to provide more extensive assistance as the disease progresses, with an emphasis on self-care and mobility.
The care required of family members can result in increased emotional stress and feelings of depression. Tailored interventions can have a positive impact on the well-being of care partners. Continued support for care partners is instrumental in treating Alzheimer’s disease holistically.